Alomide®

lodoxamide tromethamine 0.1%
ophthalmic solution
Allergy
[ Mast Cell Stabilizer]
Indication

Indication

vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis.
Mechanism of Action

Mechanism of Action

Lodoxamide tromethamine 0.1% (Alomide) stabilizes mast cells by preventing calcium influx upon antigen stimulation and decreasing vascular permeability. It inhibits theType 1 immediate hypersensitivity reaction.
Common quantities available

Available Quantities

10ml
Dosage

Dosage/Instructions

1-2 drops in affected eye four times daily for up to 3 months
Pregnancy & Nursing Data

Pregnancy & Nursing

Reproduction studies with lodoxamide tromethamine administered orally to rats and rabbits have not shown any effects of the product on fertility or reproductive performance, or any evidence of embryotoxicity or pre – and post -natal toxicity. However, there are no adequate and well controlled studies in pregnant women. Since animal reproductive studies are not always predictive of human response, ALOMIDE should be used during pregnancy only if clearly needed
Pediatric Use

Pediatric Use

>2 years
Warnings Tab

Contraindications, side effects, etc.

Contraindicated in patients with hypersensitivity to lodoxamide or any other ingredient in the product. Potential side effects include eye irritation, discomfort, or blurred vision.